GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Simris Alg AB (OSTO:SIMRIS B) » Definitions » Total Equity

Simris Alg AB (OSTO:SIMRIS B) Total Equity : kr7.47 Mil (As of Jun. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Simris Alg AB Total Equity?

Simris Alg AB's total equity for the quarter that ended in Jun. 2024 was kr7.47 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Simris Alg AB Total Equity Historical Data

The historical data trend for Simris Alg AB's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Simris Alg AB Total Equity Chart

Simris Alg AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 35.00 47.42 18.22 23.03 25.61

Simris Alg AB Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.49 30.33 25.61 17.31 7.47

Simris Alg AB Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Simris Alg AB's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity=Total Assets(Q: Dec. 2023 )-Total Liabilities(Q: Dec. 2023 )
=174.552-148.938
=25.61

Simris Alg AB's Total Equity for the quarter that ended in Jun. 2024 is calculated as

Total Equity=Total Assets(Q: Jun. 2024 )-Total Liabilities(Q: Jun. 2024 )
=165.699-158.226
=7.47

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Simris Alg AB Total Equity Related Terms

Thank you for viewing the detailed overview of Simris Alg AB's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Simris Alg AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Simris Alg AB (OSTO:SIMRIS B) » Definitions » Total Equity
Comparable Companies
OSTO:ZICC OSTO:LIPUM NGM:GTAB B OSTO:ACE XSAT:CESSA OSTO:XINT XSAT:WNT OSTO:NXTCL XSAT:DEX OSTO:BIOVIC B OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
5LU:Germany
Address
Herrestadsvagen 24A, Hammenhog, SWE, 276 50
Website
https://www.simrisalg.se
Simris Alg AB is a biotechnology company, engaged in research, development and production of bioactive substances from microalgae, for nutraceutical, cosmeceutical and pharmaceutical applications. The company's technology provides access to bioactive substances with novel functions, while replacing unsustainable raw materials from endangered marine species and ecosystems. Its first commercialised range is a series of omega-3 health supplements marketed under the company's own brand.

Simris Alg AB Headlines

No Headlines